Literature DB >> 33357715

Editorial: Cardiovascular and renal 2020: Cardiovascular protection by antidiabetic drugs: Key mechanisms and current clinical data.

Matthew W Gorr1, Loren E Wold2.   

Abstract

Entities:  

Year:  2020        PMID： 33357715      PMCID： PMC8171114          DOI： 10.1016/j.coph.2020.12.003

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN： 1471-4892            Impact factor:   5.547


× No keyword cloud information.
  7 in total

Review 1.  Evolving understanding of cardiovascular protection by SGLT2 inhibitors: focus on renal protection, myocardial effects, uric acid, and magnesium balance.

Authors:  Evan C Ray
Journal:  Curr Opin Pharmacol       Date:  2020-07-15       Impact factor: 5.547

Review 2.  Diabetes, and its treatment, as an effector of autonomic nervous system circuits and its functions.

Authors:  Liliana Espinoza; Carie R Boychuk
Journal:  Curr Opin Pharmacol       Date:  2020-07-24       Impact factor: 5.547

Review 3.  Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications.

Authors:  Shilpa N Bhupathiraju; Frank B Hu
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

Review 4.  Renal protection with glucagon-like peptide-1 receptor agonists.

Authors:  Martina Vitale; Jonida Haxhi; Tiziana Cirrito; Giuseppe Pugliese
Journal:  Curr Opin Pharmacol       Date:  2020-10-05       Impact factor: 5.547

Review 5.  Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.

Authors:  Yi Tan; Zhiguo Zhang; Chao Zheng; Kupper A Wintergerst; Bradley B Keller; Lu Cai
Journal:  Nat Rev Cardiol       Date:  2020-02-20       Impact factor: 32.419

6.  Corrigendum to "Metformin: Still the sweet spot for CV protection in diabetes?" [Curr Opin Pharmacol 54 (2020) 202-208].

Authors:  Graham Rena; Ify R Mordi; Chim C Lang
Journal:  Curr Opin Pharmacol       Date:  2021-05-11       Impact factor: 5.547

Review 7.  Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications.

Authors:  John C Chatham; Martin E Young; Jianhua Zhang
Journal:  Curr Opin Pharmacol       Date:  2020-09-13       Impact factor: 4.768
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.